These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 27039459)

  • 1. [Impact of vaccination on acute otitis media].
    Blanchard-Rohner G; Gervaix A
    Rev Med Suisse; 2016 Feb; 12(506):350-3. PubMed ID: 27039459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 13-year survey of pneumococcal nasopharyngeal carriage in children with acute otitis media following PCV7 and PCV13 implementation.
    Cohen R; Varon E; Doit C; Schlemmer C; Romain O; Thollot F; Béchet S; Bonacorsi S; Levy C
    Vaccine; 2015 Sep; 33(39):5118-26. PubMed ID: 26271823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media.
    Cohen R; Levy C; de La Rocque F; Gelbert N; Wollner A; Fritzell B; Bonnet E; Tetelboum R; Varon E
    Pediatr Infect Dis J; 2006 Nov; 25(11):1001-7. PubMed ID: 17072121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal nasopharyngeal carriage in children with acute otitis media.
    Cohen R; Levy C; Bingen E; Koskas M; Nave I; Varon E
    Pediatr Infect Dis J; 2012 Mar; 31(3):297-301. PubMed ID: 22330166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pneumococcal conjugate vaccination in children with recurrent acute otitis media: a therapeutic alternative?
    van Kempen MJ; Vermeiren JS; Vaneechoutte M; Claeys G; Veenhoven RH; Rijkers GT; Sanders EA; Dhooge IJ
    Int J Pediatr Otorhinolaryngol; 2006 Feb; 70(2):275-85. PubMed ID: 16140397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumococcal conjugate vaccines for preventing otitis media.
    Fortanier AC; Venekamp RP; Boonacker CW; Hak E; Schilder AG; Sanders EA; Damoiseaux RA
    Cochrane Database Syst Rev; 2014 Apr; (4):CD001480. PubMed ID: 24696098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling the decline in pneumococcal acute otitis media following the introduction of pneumococcal conjugate vaccines in the US.
    Shea KM; Weycker D; Stevenson AE; Strutton DR; Pelton SI
    Vaccine; 2011 Oct; 29(45):8042-8. PubMed ID: 21871518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nasopharyngeal pneumococcal carriage after combined pneumococcal conjugate and polysaccharide vaccination in children with a history of recurrent acute otitis media.
    Veenhoven RH; Bogaert D; Schilder AG; Rijkers GT; Uiterwaal CS; Kiezebrink HH; van Kempen MJ; Dhooge IJ; Bruin J; Ijzerman EP; de Groot R; Kuis W; Hermans PW; Sanders EA
    Clin Infect Dis; 2004 Oct; 39(7):911-9. PubMed ID: 15472839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pneumococcal conjugate vaccination on nasopharyngeal carriage in children with early onset of acute otitis media - a randomized controlled trial.
    Gisselsson-Solén M; Henriksson G; Hermansson A; Melhus A
    Acta Otolaryngol; 2015 Jan; 135(1):7-13. PubMed ID: 25496176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotype coverage of invasive and mucosal pneumococcal disease in Israeli children younger than 3 years by various pneumococcal conjugate vaccines.
    Shouval DS; Greenberg D; Givon-Lavi N; Porat N; Dagan R
    Pediatr Infect Dis J; 2009 Apr; 28(4):277-82. PubMed ID: 19258924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumococcal conjugate vaccines for preventing otitis media.
    Jansen AG; Hak E; Veenhoven RH; Damoiseaux RA; Schilder AG; Sanders EA
    Cochrane Database Syst Rev; 2009 Apr; (2):CD001480. PubMed ID: 19370566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic Resistance of Potential Otopathogens Isolated From Nasopharyngeal Flora of Children With Acute Otitis Media Before, During and After Pneumococcal Conjugate Vaccines Implementation.
    Rybak A; Levy C; Bonacorsi S; Béchet S; Vié le Sage F; Elbez A; Varon E; Cohen R
    Pediatr Infect Dis J; 2018 Mar; 37(3):e72-e78. PubMed ID: 29227464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in treatment strategies for acute otitis media after full implementation of the pneumococcal seven valent conjugate vaccine.
    Harrison CJ
    Pediatr Infect Dis J; 2003 Aug; 22(8 Suppl):S120-30. PubMed ID: 14566998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pneumococcal conjugate vaccine on nasopharyngeal bacterial colonization during acute otitis media.
    Revai K; McCormick DP; Patel J; Grady JJ; Saeed K; Chonmaitree T
    Pediatrics; 2006 May; 117(5):1823-9. PubMed ID: 16651345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for carriage of AOM pathogens during the first 3 years of life in children with early onset of acute otitis media.
    Gisselsson-Solén M; Henriksson G; Hermansson A; Melhus A
    Acta Otolaryngol; 2014 Jul; 134(7):684-90. PubMed ID: 24834935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of a 7-valent pneumococcal conjugate vaccine (PCV7) and impact on carriage in Venezuelan children at risk of invasive pneumococcal diseases.
    Rivera-Olivero IA; Del Nogal B; Fuentes M; Cortez R; Bogaert D; Hermans PW; Waard JH
    Vaccine; 2014 Jun; 32(31):4006-11. PubMed ID: 24837505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does pneumococcal conjugate vaccination affect onset and risk of first acute otitis media and recurrences? A primary care-based cohort study.
    Fortanier AC; Venekamp RP; Hoes AW; Schilder AGM
    Vaccine; 2019 Mar; 37(11):1528-1532. PubMed ID: 30738648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct and indirect effects of the 13-valent pneumococcal conjugate vaccine administered to infants and young children.
    Esposito S; Principi N;
    Future Microbiol; 2015; 10(10):1599-607. PubMed ID: 26439470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of a 10- versus 13-valent pneumococcal conjugate vaccine in Denmark and Sweden.
    Klok RM; Lindkvist RM; Ekelund M; Farkouh RA; Strutton DR
    Clin Ther; 2013 Feb; 35(2):119-34. PubMed ID: 23312274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decline in Pneumococcal Nasopharyngeal Carriage of Vaccine Serotypes After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Children in Atlanta, Georgia.
    Desai AP; Sharma D; Crispell EK; Baughman W; Thomas S; Tunali A; Sherwood L; Zmitrovich A; Jerris R; Satola SW; Beall B; Moore MR; Jain S; Farley MM
    Pediatr Infect Dis J; 2015 Nov; 34(11):1168-74. PubMed ID: 26226445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.